Bayesian Capital Management, LP Harmony Biosciences Holdings, Inc. Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$28.81 - $33.01 $300,257 - $344,030
10,422 New
10,422 $314,000
Q1 2023

May 15, 2023
BUY
$30.8 - $53.92 $541,402 - $947,805
17,578 New
17,578 $573,000
Q2 2022

Aug 15, 2022
SELL
$33.54 - $52.15 $144,222 - $224,245
-4,300 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$33.14 - $51.13 $142,502 - $219,859
4,300 New
4,300 $209,000

Others Institutions Holding HRMY

# of Institutions
243
Shares Held
45.2M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.04B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email